vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Commercial Vehicle Group, Inc. (CVGI). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $154.8M, roughly 1.8× Commercial Vehicle Group, Inc.). On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -5.2%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -10.8%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
ACAD vs CVGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $284.0M | $154.8M |
| Net Profit | $273.6M | — |
| Gross Margin | 90.8% | 9.7% |
| Operating Margin | 6.1% | -1.2% |
| Net Margin | 96.3% | — |
| Revenue YoY | 9.4% | -5.2% |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $154.8M | ||
| Q3 25 | $278.6M | $152.5M | ||
| Q2 25 | $264.6M | $172.0M | ||
| Q1 25 | $244.3M | $169.8M | ||
| Q4 24 | $259.6M | $163.3M | ||
| Q3 24 | $250.4M | $171.8M | ||
| Q2 24 | $242.0M | $193.7M | ||
| Q1 24 | $205.8M | $194.6M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $-7.1M | ||
| Q2 25 | $26.7M | $-4.8M | ||
| Q1 25 | $19.0M | $-4.3M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $9.5M | ||
| Q2 24 | $33.4M | $-1.6M | ||
| Q1 24 | $16.6M | $2.9M |
| Q4 25 | 90.8% | 9.7% | ||
| Q3 25 | 92.2% | 10.5% | ||
| Q2 25 | 92.2% | 11.4% | ||
| Q1 25 | 91.7% | 10.5% | ||
| Q4 24 | 91.6% | 8.0% | ||
| Q3 24 | 92.5% | 9.6% | ||
| Q2 24 | 92.5% | 10.6% | ||
| Q1 24 | 88.8% | 11.9% |
| Q4 25 | 6.1% | -1.2% | ||
| Q3 25 | 12.8% | -0.7% | ||
| Q2 25 | 12.2% | 0.5% | ||
| Q1 25 | 7.9% | 0.8% | ||
| Q4 24 | 59.1% | -3.2% | ||
| Q3 24 | 12.6% | -0.6% | ||
| Q2 24 | 12.6% | 0.5% | ||
| Q1 24 | 7.4% | 2.3% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | -4.6% | ||
| Q2 25 | 10.1% | -2.8% | ||
| Q1 25 | 7.8% | -2.5% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | 5.5% | ||
| Q2 24 | 13.8% | -0.8% | ||
| Q1 24 | 8.0% | 1.5% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $0.20 | $-0.05 | ||
| Q1 24 | $0.10 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | — |
| Total DebtLower is stronger | — | $104.9M |
| Stockholders' EquityBook value | $1.2B | $133.4M |
| Total Assets | $1.6B | $391.7M |
| Debt / EquityLower = less leverage | — | 0.79× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — | ||
| Q1 24 | $204.7M | — |
| Q4 25 | — | $104.9M | ||
| Q3 25 | — | $108.2M | ||
| Q2 25 | — | $118.2M | ||
| Q1 25 | — | $117.4M | ||
| Q4 24 | — | $135.5M | ||
| Q3 24 | — | $128.8M | ||
| Q2 24 | — | $142.0M | ||
| Q1 24 | — | $155.7M |
| Q4 25 | $1.2B | $133.4M | ||
| Q3 25 | $917.3M | $136.5M | ||
| Q2 25 | $822.4M | $142.6M | ||
| Q1 25 | $765.2M | $136.7M | ||
| Q4 24 | $732.8M | $135.6M | ||
| Q3 24 | $577.2M | $179.3M | ||
| Q2 24 | $516.7M | $169.6M | ||
| Q1 24 | $464.0M | $175.5M |
| Q4 25 | $1.6B | $391.7M | ||
| Q3 25 | $1.3B | $400.3M | ||
| Q2 25 | $1.2B | $429.8M | ||
| Q1 25 | $1.1B | $419.8M | ||
| Q4 24 | $1.2B | $424.6M | ||
| Q3 24 | $976.9M | $495.3M | ||
| Q2 24 | $914.1M | $503.2M | ||
| Q1 24 | $855.1M | $509.2M |
| Q4 25 | — | 0.79× | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 1.00× | ||
| Q3 24 | — | 0.72× | ||
| Q2 24 | — | 0.84× | ||
| Q1 24 | — | 0.89× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $12.3M |
| Free Cash FlowOCF − Capex | — | $8.7M |
| FCF MarginFCF / Revenue | — | 5.6% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $12.3M | ||
| Q3 25 | $74.3M | $-1.7M | ||
| Q2 25 | $64.0M | $18.9M | ||
| Q1 25 | $20.3M | $15.2M | ||
| Q4 24 | $40.4M | $-26.6M | ||
| Q3 24 | $63.2M | $-17.1M | ||
| Q2 24 | $25.0M | $12.6M | ||
| Q1 24 | $29.1M | $-2.4M |
| Q4 25 | — | $8.7M | ||
| Q3 25 | $73.9M | $-3.5M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $-30.6M | ||
| Q3 24 | $63.2M | $-20.3M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $-7.4M |
| Q4 25 | — | 5.6% | ||
| Q3 25 | 26.5% | -2.3% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | -18.7% | ||
| Q3 24 | 25.2% | -11.8% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | -3.8% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | 0.1% | 1.2% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 0.0% | 1.9% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | -1.79× | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | -0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |